SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000902664-24-002264
Filing Date
2024-03-07
Accepted
2024-03-07 16:15:10
Documents
2

Document Format Files

Seq Description Document Type Size
1 TERNS PHARMACEUTICALS, INC. p24-1156sc13g.htm SC 13G 75348
2 JOINT FILING AGREEMENT PURSUANT TO RULE 13D-1(K) exhibit_99.htm EX-99 8199
  Complete submission text file 0000902664-24-002264.txt   85114
Mailing Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902
Business Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902 203-890-2000
Point72 Asset Management, L.P. (Filed by) CIK: 0001603466 (see all company filings)

IRS No.: 465064661 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Subject) CIK: 0001831363 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92116 | Film No.: 24730283
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)